Talking to CNBC-TV18, Vijay says that the main focus is on developing railway infrastructure. Engineering, procurement, construction (EPC) projects will be the most profitable in future, he adds.
Posts tagged MC
Stalled rail projects reviving; focus to be on EPC: Texmaco (16-09-2015)
Sadbhav Infrastructure Project debuts at Rs 111, up 8% (16-09-2015)
In fact, it was better than expected listing because analysts were expecting to be bad debut due to its debt burden of Rs 6,600 crore.
Mkts will rally before earnings turn around: HSBC AMC CIO (16-09-2015)
The Indian earnings story has been delayed inordinately and may take another two quarters at least to come through but markets will start discounting them before that, says Tushar Pradhan, CIO at HSBC Global Asset Management (India).
Sun Pharma seals deal to acquire US-based InSite Vision (16-09-2015)
“The transaction has a total equity value of approximately USD 48 million on a fully-diluted basis plus related debt and other transaction costs assuming all shares of InSite Vision are tendered in the offer,” it added.
A buyer’s market for investors; like auto ancillaries: IIFL (16-09-2015)
The severe competition amongst auto companies could in fact help the ancillary space, especially when there is a constant demand for new innovative products for new models, says Amar Ambani of IIFL.
Deutsche Bank downgrades Tata Motors, cuts target by 21% (16-09-2015)
Deutsche Bank believes that the impact on margins (down 290 basis points by FY18) and free cash flow will be stronger than earlier anticipated. Hence it cut earnings per share forecasts by 17-23 percent and target price by 21 percent to Rs 375.
Sensex, Nifty remain strong; Sadbhav Infra lists at Rs 111 (16-09-2015)
Sadbhav Infrastructure Project has listed at Rs 111 on the National Stock Exchange, higher by 7.8 percent over its issue price of Rs 103.
Amendments to road agreements to boost highways: Crisil (16-09-2015)
According to Crisil Research, amendments including – back ending of premium payments, deemed termination of projects, allowing greater equity contribution by the NHAI, stringent penalties on non-compliance of maintenance contracts and collection of real-time traffic data – will improve the confidence of developers and lenders in the sector.
Sun Pharma to acquire InSite Vision; stock gains 2.3% (16-09-2015)
InSite Vision focuses on developing new specialty ophthalmic products, including three late stage programs.
Prabhudas CEO sees relief rally even if Fed hikes (16-09-2015)
Markets are poised for a relief rally even if the Federal Reserve hikes interest rates for the first time in nine years, and it is likely the US central bank will do it, to “call the bluff of scaremongers”, believes Ajay Bodke of brokerage firm Prabhudas Lilladher.